Compare FSS & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FSS | IBRX |
|---|---|---|
| Founded | 1901 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.8B | 7.5B |
| IPO Year | 1994 | 2015 |
| Metric | FSS | IBRX |
|---|---|---|
| Price | $128.29 | $7.59 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 7 |
| Target Price | ★ $131.75 | $12.57 |
| AVG Volume (30 Days) | 438.3K | ★ 9.0M |
| Earning Date | 04-29-2026 | 05-08-2026 |
| Dividend Yield | ★ 0.46% | N/A |
| EPS Growth | 14.57 | ★ 38.71 |
| EPS | ★ 2.54 | N/A |
| Revenue | ★ $2,180,500,000.00 | $113,288,000.00 |
| Revenue This Year | $20.94 | $88.59 |
| Revenue Next Year | $6.79 | $131.15 |
| P/E Ratio | $49.80 | ★ N/A |
| Revenue Growth | 17.14 | ★ 668.31 |
| 52 Week Low | $101.19 | $1.95 |
| 52 Week High | $134.51 | $12.43 |
| Indicator | FSS | IBRX |
|---|---|---|
| Relative Strength Index (RSI) | 59.20 | 51.28 |
| Support Level | $106.17 | $6.68 |
| Resistance Level | $132.26 | $8.46 |
| Average True Range (ATR) | 4.32 | 0.38 |
| MACD | 0.75 | 0.05 |
| Stochastic Oscillator | 78.48 | 89.05 |
Federal Signal Corp designs and manufactures products and integrated solutions for municipal, governmental, industrial, and airport customers. It operates through two segments. The Environmental Solutions Group manufactures and supplies street sweeper vehicles, sewer cleaner and vacuum loader trucks, hydro-excavation trucks, high-performance water blasting equipment, dump truck bodies, and trailers. The Safety and Security Systems Group manufactures and supplies comprehensive systems and products used by law enforcement, fire rescue, and industrial sites to protect people and property. Its offerings include systems for community alerting and industrial communications. The company generates the majority of its revenue from the Environmental Solutions Group segment.
ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.